-adrenergic receptor agonist therapy for asthma is associated with an increased risk of cardiac events

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1199, 2008-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiazolidinedione treatment is not associated with an increased risk of major adverse cardiovascular events

By  

Inpharma, Vol. 1, Iss. 1643, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Is the Use of Selective COX Inhibitors Associated with an Increased Risk of Cardiovascular Events?

By  

Heart Drug, Vol. 4, Iss. 2, 2004-05 ,pp. : 92-95

Karger

Access to resources Recommend Favorite

Identification of Small Molecule as a High Affinity β2 Agonist Promiscuously Targeting Wild and Mutated (Thr164Ile) β 2 Adrenergic Receptor in the Treatment of Bronchial Asthma

By  

Current Pharmaceutical Design, Vol. 22, Iss. 34, 2016-09 ,pp. : 5221-5233

Bentham Science Publishers

Access to resources Recommend Favorite

β-Adrenergic receptor polymorphisms: relationship to the β-agonist controversy and clinical implications

By Taylor D Robin  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 18, 2007-12 ,pp. : 3195-3203

Informa Healthcare

Access to resources Recommend Favorite

Increased risk of thromboembolic events with Avastin

By  

Reactions Weekly, Vol. 1, Iss. 1015, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite